Efficacy Of Trimeprazine Tartrate In Behavior
Management Of Uncooperative Pediatric Dental Patients

Lanre L. Bello, Sami'a K. Darwish, BDS, MS
King Saud Univer­sity College of Dentistry, P.O. Box 60169, Riyadh 11545, Saudi Arabia

This study was carried out to determine the effectiveness of different doses oftrimeprazine tar­trate (Vallergan®) when uncooperative and fearful children were sedated for dental treatment, Thirty children took part in the study, ranging in age from 30 months to 60 months with a mean age of 42.8 months. The subjects were randomly assigned to receive 0.0 mg, 2.5 mg, 3.0 mg, 3.5 mg and 4.0 mg of the medication per kilogram body weight, respectively, Behavior was assessed in terms of the degree of sleep, crying and body movements during specific treatment procedures. Significant improvement in behavior as evidenced by tack of crying and/or body movement in which interrupted treatment was found in 88% and 75% of the children adminis­tered 4.0 mg and 3.5 mg, respectively in contrast to 38%, 0% and 0% of those administered 3.0 mg, 2.5 mg and 0.0 mg oftrimeprazine, respectively. No significant effect on vital signs was observed during the course of treatment.

Saudi Dental Journal 1994;6(3):160-168.